Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA
RESEARCH TOOLSreports
Medicenna Therapeutics Corp (MDNA) Stock Forecast & Price Target
163 Followers
See the Price Targets and Ratings of:
MDNA Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDNA Stock 12 Month Forecast
There Are No Analyst Ratings for TSE:MDNA In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
MDNA Financial Forecast
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Bloom Burton
C$8.26
Buy
C$8.26
(334.89% Upside)
Reiterated
04/10/24
We expect that cash of 31 should be sufficient to fund operations into 2Q-2025. Rating: BUY Target: Outstanding (MM) 69.6 Market Cap. (MM) C$105.8 Cash per share C$0.31 Avg. Report is priced as of prior trading close. All values in CAD unless otherwise noted.
JonesTrading
C$5
Buy
C$5.00
(163.16% Upside)
Reiterated
04/10/24
Medicenna reported MDNA11 monotherapy dose escalation and dose expansion data at AACR ( press release ). There was an additional PR, bringing the total number of clinical responses up to n=3 PRs and n=1 iPR across dose escalation and expansion. In Ph2 eligible patients receiving ≥60 ug/kg, ORR was 29% (4/14). In the expansion arm, ORR per RECIST was 25% (1/4) and ORR per iRECIST was 50% (2/4).
Research Capital
C$2.2
Buy
C$2.20
(15.97% Upside)
Reiterated
02/14/24
MDNA is undervalued, Research Capital saysBy Nick Waddell Published on February 15, 2024 Last Updated on February 15, 2024 Filed under: All posts , Analysts , Life Sciences Stock: mdnaMDNA is undervalued, Research Capital says
Oppenheimer
C$11.02→C$4.13
Buy
C$4.13
(117.44% Upside)
Reiterated
08/14/23
Medicenna Therapeutics price target lowered to $3 from $8 at OppenheimerMedicenna Therapeutics price target lowered to $3 from $8 at Oppenheimer
Best Analysts Covering Medicenna Therapeutics Corp
Which Analyst Should I Follow If I Want to Buy TSE:MDNA and Sell After:
1 Month
xxx
Success Rate
3/11 ratings generated profit
Average Return
-6.99%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 27.27% of your transactions generating a profit, with an average return of -6.99% per trade.
3 Months
xxx
Success Rate
3/14 ratings generated profit
Average Return
-18.57%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 21.43% of your transactions generating a profit, with an average return of -18.57% per trade.
1 Year
Success Rate
3/14 ratings generated profit
Average Return
+8.17%
reiterated a buy rating 3 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of +8.17% per trade.
2 Years
xxx
Success Rate
9/14 ratings generated profit
Average Return
+57.96%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +57.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDNA Analyst Recommendation Trends
Rating
Aug 23
Oct 23
Nov 23
Feb 24
Apr 24
Strong Buy
5
5
6
4
5
Buy
0
0
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
6
4
6
Each month's total comprises the sum of three months' worth of ratings.
MDNA Stock Forecast FAQ
What is TSE:MDNA’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:MDNA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:MDNA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:MDNA a Buy, Sell or Hold?
Currently, no data Available
What is Medicenna Therapeutics Corp’s price target?
Currently, no data Available
What do analysts say about Medicenna Therapeutics Corp?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TSE:MDNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.